Juliana M. Layzer

1.9k total citations
20 papers, 1.4k citations indexed

About

Juliana M. Layzer is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Juliana M. Layzer has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Immunology. Recurrent topics in Juliana M. Layzer's work include Advanced biosensing and bioanalysis techniques (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and RNA Interference and Gene Delivery (5 papers). Juliana M. Layzer is often cited by papers focused on Advanced biosensing and bioanalysis techniques (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and RNA Interference and Gene Delivery (5 papers). Juliana M. Layzer collaborates with scholars based in United States, Australia and Denmark. Juliana M. Layzer's co-authors include Bruce A. Sullenger, Alice Tanner, Mark A. Kay, Zan Huang, Anton P. McCaffrey, George A. Pitoc, Dougald M. Monroe, Christopher P. Rusconi, Thomas L. Ortel and Smita K. Nair and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Juliana M. Layzer

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juliana M. Layzer United States 12 1.2k 179 162 156 130 20 1.4k
George A. Pitoc United States 12 798 0.7× 176 1.0× 150 0.9× 48 0.3× 133 1.0× 18 1.2k
Jen‐Chieh Tseng United States 18 1.0k 0.9× 169 0.9× 121 0.7× 108 0.7× 184 1.4× 35 1.6k
Staffan Sandgren Sweden 12 871 0.8× 192 1.1× 52 0.3× 84 0.5× 229 1.8× 13 1.3k
Ian M. Kaplan United States 8 775 0.7× 115 0.6× 36 0.2× 64 0.4× 202 1.6× 16 1.2k
Daniel M. Dupont Denmark 19 637 0.6× 170 0.9× 129 0.8× 381 2.4× 50 0.4× 37 978
Alicia L. Carlson United States 11 419 0.4× 245 1.4× 206 1.3× 44 0.3× 340 2.6× 15 1000
Karin Gaensler United States 20 1.0k 0.9× 167 0.9× 58 0.4× 70 0.4× 131 1.0× 42 1.4k
Ryan L. Setten United States 8 1.1k 0.9× 31 0.2× 110 0.7× 284 1.8× 106 0.8× 10 1.3k
Manuela Schuksz United States 6 1.1k 0.9× 125 0.7× 38 0.2× 124 0.8× 108 0.8× 8 1.7k
Andrey S. Dobroff United States 21 761 0.7× 55 0.3× 98 0.6× 171 1.1× 270 2.1× 35 1.2k

Countries citing papers authored by Juliana M. Layzer

Since Specialization
Citations

This map shows the geographic impact of Juliana M. Layzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliana M. Layzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliana M. Layzer more than expected).

Fields of papers citing papers by Juliana M. Layzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliana M. Layzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliana M. Layzer. The network helps show where Juliana M. Layzer may publish in the future.

Co-authorship network of co-authors of Juliana M. Layzer

This figure shows the co-authorship network connecting the top 25 collaborators of Juliana M. Layzer. A scholar is included among the top collaborators of Juliana M. Layzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliana M. Layzer. Juliana M. Layzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Layzer, Juliana M., et al.. (2024). An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences. 121(29). e2401136121–e2401136121. 5 indexed citations
2.
Yu, Haixiang, James W. Frederiksen, George A. Pitoc, et al.. (2024). Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors. Nature Communications. 15(1). 3977–3977. 6 indexed citations
3.
Gray, Bethany Powell, Juliana M. Layzer, Rachel E. Rempel, et al.. (2023). Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes. Molecular Therapy — Nucleic Acids. 31. 440–451. 5 indexed citations
4.
Corsi, Giulia I., et al.. (2023). Utilizing directed evolution to interrogate and optimize CRISPR/Cas guide RNA scaffolds. Cell chemical biology. 30(8). 879–892.e5. 5 indexed citations
5.
6.
Özer, İmran, George A. Pitoc, Juliana M. Layzer, et al.. (2022). PEG‐Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response. Advanced Materials. 34(10). e2107852–e2107852. 32 indexed citations
7.
Bonadonna, Desiree, James Otto, Charlene V. Chabata, et al.. (2021). Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO. Molecular Therapy — Nucleic Acids. 27. 524–534. 11 indexed citations
8.
Pitoc, George A., Nancy J. Ganson, Juliana M. Layzer, et al.. (2019). Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers. Cell chemical biology. 26(5). 634–644.e3. 72 indexed citations
9.
Wheeler, Debra G., Surya Gnyawali, David Dornbos, et al.. (2018). Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury. Journal of Visualized Experiments. 6 indexed citations
10.
Wheeler, Debra G., Surya Gnyawali, David Dornbos, et al.. (2018). Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury. Journal of Visualized Experiments. 4 indexed citations
11.
Layzer, Juliana M., et al.. (2017). A kallikrein‐targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release. Journal of Thrombosis and Haemostasis. 15(9). 1807–1817. 17 indexed citations
12.
Xu, Yiming, et al.. (2013). Inhibiting the intrinsic pathway of coagulation with a factor XII–targeting RNA aptamer. Journal of Thrombosis and Haemostasis. 11(7). 1364–1373. 78 indexed citations
13.
Rusconi, Christopher P., et al.. (2010). Abstract 10787: Discovery of a Novel Aptamer-based Inhibitor of GPVI and its Matched Active Control Agent. Circulation. 122. 1 indexed citations
14.
Layzer, Juliana M., Genmin Lu, Christopher P. Rusconi, et al.. (2009). An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase. Journal of Biological Chemistry. 285(8). 5212–5223. 37 indexed citations
15.
Nair, Smita K., David Boczkowski, Jae Wook Lee, et al.. (2008). Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer. Chemistry & Biology. 15(7). 675–682. 150 indexed citations
16.
Giangrande, Paloma H., Jianxin Zhang, Alice Tanner, et al.. (2007). Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proceedings of the National Academy of Sciences. 104(32). 12988–12993. 35 indexed citations
17.
Layzer, Juliana M. & Bruce A. Sullenger. (2007). Simultaneous Generation of Aptamers to Multiple Gamma-Carboxyglutamic Acid Proteins from a Focused Aptamer Library Using DeSELEX and Convergent Selection. Oligonucleotides. 17(1). 1–11. 54 indexed citations
18.
Nimjee, Shahid M., Juliana M. Layzer, David Ginsburg, et al.. (2007). Antidote-Controlled Platelet Inhibition Targeting von Willebrand Factor with Aptamers. Oligonucleotides. 17(3). 265–274. 52 indexed citations
19.
Layzer, Juliana M., Anton P. McCaffrey, Alice Tanner, et al.. (2004). In vivo activity of nuclease-resistant siRNAs. RNA. 10(5). 766–771. 450 indexed citations
20.
Rusconi, Christopher P., Juliana M. Layzer, George A. Pitoc, et al.. (2002). RNA aptamers as reversible antagonists of coagulation factor IXa. Nature. 419(6902). 90–94. 416 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George A. Pitoc Breakdown of academic impact, for papers by Jen‐Chieh Tseng Breakdown of academic impact, for papers by Staffan Sandgren Breakdown of academic impact, for papers by Ian M. Kaplan Breakdown of academic impact, for papers by Daniel M. Dupont Breakdown of academic impact, for papers by Alicia L. Carlson Breakdown of academic impact, for papers by Karin Gaensler Breakdown of academic impact, for papers by Ryan L. Setten Breakdown of academic impact, for papers by Manuela Schuksz Breakdown of academic impact, for papers by Andrey S. Dobroff
Rankless by CCL
2026